HIS
TGTX icon

Harvest Investment Services’s TG Therapeutics TGTX Stock Holding History

Harvest Investment Services’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-56,359
Closed -$2.03M – 375
2025
Q2 		$2.03M Buy
56,359
+33,381
+145% +$1.24M 0.45% 54
2025
Q1 		$906K Buy
+22,978
New +$773K 0.25% 98
2023
Q3 		– Sell
-44,471
Closed -$1.1M – 196
2023
Q2 		$1.1M Buy
44,471
+3,742
+9% +$96.7K 0.63% 53
2023
Q1 		$613K Buy
+40,729
New +$619K 0.47% 58

Other funds holding TGTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Harvest Investment Services's TGTX Position: Q3 2025 in Review

Harvest Investment Services sold out of TG Therapeutics (TGTX) in Q3 2025, closing a stake of 56,359 shares — an estimated $2.03M sold.

Harvest Investment Services first reported a position in TGTX in Q1 2023 and held it in 4 quarters. The position peaked at $2.03M in Q2 2025. 354 funds tracked by Wall St. Rank hold TGTX as of Q3 2025.

  • Harvest Investment Services reported no remaining TG Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Harvest Investment Services sold 56,359 TG Therapeutics shares in Q3 2025, an estimated $2.03M.
  • Harvest Investment Services first reported a position in TG Therapeutics in Q1 2023 and held it in 4 quarters.
  • Harvest Investment Services's TG Therapeutics position peaked at $2.03M in Q2 2025.
  • 354 funds tracked by Wall St. Rank held TG Therapeutics as of Q3 2025.

Based on Harvest Investment Services's 13F filing for Q3 2025, filed 17 Nov 2025.